ACADIA Pharmaceuticals(us:ACAD)

    17.16

    +1.72%

    Updated on 2024-12-23

    Open:16.86
    Close:17.16
    High:17.19
    Low:16.62
    Pre Close:16.87
    Volume:529357.00
    Amount:8.97M
    Turnover:0.32%
    Shares:166.39M
    MarketCap:2.85B
    Total 1 records
    codechangetotalincreasedecreaserps5rps10rps15rps20

    Biote...

    BK2069

    +0.60%67230535331142442

    About

    ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
    Address:12830 El Camino Real,Suite 400

    Market Movers